PTC THERAPEUTICS, INC. Quarterly Amortization of Intangible Assets in USD from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Ptc Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2016 to Q3 2024.
  • Ptc Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $3.04M, a 94.8% decline year-over-year.
  • Ptc Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $135M, a 25.7% decline year-over-year.
  • Ptc Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $223M, a 91% increase from 2022.
  • Ptc Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $117M, a 113% increase from 2021.
  • Ptc Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $54.8M, a 48.4% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $135M $3.04M -$55.6M -94.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $190M $2.87M -$44.5M -94% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $235M $51.5M +$12.1M +30.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $223M $77.2M +$41.4M +116% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $181M $58.6M +$27.6M +89.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $154M $47.4M +$21.1M +80.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $132M $39.4M +$15.9M +67.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $117M $35.8M +$19.4M +119% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $97.1M $31M +$16.6M +116% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $80.5M $26.3M +$13.5M +106% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $66.9M $23.5M +$12.2M +108% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $54.8M $16.3M +$5.76M +54.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $49M $14.4M +$4.75M +49.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $44.2M $12.8M +$4.02M +46% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $40.2M $11.3M +$3.33M +41.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $36.9M $10.6M +$2.61M +32.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $34.3M $9.63M +$2.61M +37.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $31.7M $8.73M +$2.16M +32.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $29.5M $7.95M +$1.87M +30.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $27.7M $7.97M +$1.91M +31.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $25.7M $7.03M +$1.23M +21.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $24.5M $6.58M +$982K +17.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $23.5M $6.08M +$649K +12% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $22.9M $6.06M +$399K +7.04% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $22.5M $5.79M -$3.92M -40.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $26.4M $5.59M +$5.59M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $20.8M $5.43M +$5.43M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $15.4M $5.66M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $9.72M +$9.72M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q3 2016 $0 Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.